@ariadnatibau.bsky.social
Reposted
⭐Out now from Dr. Jerry Avorn— RETHINKING MEDICATIONS: Truth, Power, and the Drugs You Take
In his new book, Dr. Avorn explains why some of the medications we take are poorly evaluated, overpriced, or pose unwarranted risks—and how we fix that.
📖 Grab a copy today: rethinkmeds.info
In his new book, Dr. Avorn explains why some of the medications we take are poorly evaluated, overpriced, or pose unwarranted risks—and how we fix that.
📖 Grab a copy today: rethinkmeds.info
Home
Truth, Power, and the Drugs You Take
rethinkmeds.info
April 30, 2025 at 6:58 PM
⭐Out now from Dr. Jerry Avorn— RETHINKING MEDICATIONS: Truth, Power, and the Drugs You Take
In his new book, Dr. Avorn explains why some of the medications we take are poorly evaluated, overpriced, or pose unwarranted risks—and how we fix that.
📖 Grab a copy today: rethinkmeds.info
In his new book, Dr. Avorn explains why some of the medications we take are poorly evaluated, overpriced, or pose unwarranted risks—and how we fix that.
📖 Grab a copy today: rethinkmeds.info
Reposted
And, on strategies to improve the biosimilar market, including by implementing policies to facilitate biosimilar interchangeability, clear patent thickets, and preventing biosimilar rebate gaming by PBMs.
April 9, 2025 at 1:57 PM
And, on strategies to improve the biosimilar market, including by implementing policies to facilitate biosimilar interchangeability, clear patent thickets, and preventing biosimilar rebate gaming by PBMs.
Reposted
WATCH: @akesselheim.bsky.social testifies before @waysmeanscmte.bsky.social
On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."
On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."
April 9, 2025 at 1:57 PM
WATCH: @akesselheim.bsky.social testifies before @waysmeanscmte.bsky.social
On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."
On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."
Reposted
Reposted
New piece led by Anushka Bhaskar @portalresearch.org in STAT First Opinion on protecting public health agencies from damaging political interference -- even the threat of which can greatly affect people's behavior: www.statnews.com/2025/01/31/p...
How to protect HHS, FDA, NIH, and other health agencies from political interference
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts and inflict lasting damage on institutional credibility.
www.statnews.com
January 31, 2025 at 2:27 PM
New piece led by Anushka Bhaskar @portalresearch.org in STAT First Opinion on protecting public health agencies from damaging political interference -- even the threat of which can greatly affect people's behavior: www.statnews.com/2025/01/31/p...
Reposted
Check out the February edition of the PORTAL Post, featuring analysis on:
- the promise and risk of drug repurposing,
- drug importation to address shortages,
- use of subgroup analysis in cost-effectiveness studies
- biosimilar patent litigation,
- and much more!
#medsky #healthpolicy
- the promise and risk of drug repurposing,
- drug importation to address shortages,
- use of subgroup analysis in cost-effectiveness studies
- biosimilar patent litigation,
- and much more!
#medsky #healthpolicy
PORTAL Post | February 2025
Protecting health agency independence, drug repurposing, academic detailing, and more from the PORTAL team.
mailchi.mp
February 6, 2025 at 3:53 PM
Check out the February edition of the PORTAL Post, featuring analysis on:
- the promise and risk of drug repurposing,
- drug importation to address shortages,
- use of subgroup analysis in cost-effectiveness studies
- biosimilar patent litigation,
- and much more!
#medsky #healthpolicy
- the promise and risk of drug repurposing,
- drug importation to address shortages,
- use of subgroup analysis in cost-effectiveness studies
- biosimilar patent litigation,
- and much more!
#medsky #healthpolicy
Reposted
📣PORTAL is hiring! 📣
There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024.
Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025
There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024.
Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025
Deadline Approaching - Join the PORTAL Team!
Apply by December 1, 2024 to be a PORTAL Postdoctoral or General Medicine Fellow. We are also accepting applications for a Faculty Member in Health Policy or Health Services Research.
mailchi.mp
November 21, 2024 at 5:31 PM
📣PORTAL is hiring! 📣
There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024.
Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025
There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024.
Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025
Reposted
Among the government-funded academic inventors on US drug patents, the majority were senior researchers at prestigious institutions.
https://ja.ma/48YWpKB
https://ja.ma/48YWpKB
November 21, 2024 at 5:00 PM
Among the government-funded academic inventors on US drug patents, the majority were senior researchers at prestigious institutions.
https://ja.ma/48YWpKB
https://ja.ma/48YWpKB